Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACE: Prednisolone for Acute Facial Nerve Palsy in Children
NCT03781700Phase 4Completed
- Sponsor
- Region Dalarna
- Start
- May 2019
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in facial nerve palsy comparing Prednisolone with Placebo (2 arms). Primary endpoint: House-Brackmann scale at 12 months. Started May 2019; status: completed.
02
Drugs
prednisolone
03
Conditions
facial nerve palsy
Beyond the preview
Go deeper on NCT03781700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781700.